Search

everythinglearnresearchcommunity

for

Search:↓

A woman permanently lost hair on her scalp after a long surgery.

The patient accepted her hair loss and adapted by wearing a wig and tattooing her eyebrows.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

Non-Hispanic Black and Hispanic female service members have the highest rates of hair loss.

Finasteride may help treat hair loss in postmenopausal women.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The study concluded that hair loss treatments should be tailored to the specific type of alopecia and individual patient needs.

Bariatric surgery often causes temporary hair loss due to stress and nutrient deficiencies.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hair transplantation can effectively treat female pattern hair loss if done correctly, considering factors like patient's preferred hairstyle and proper use of techniques and medications.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Female pattern hair loss is more common among Indian women than previously believed.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The document suggests managing female pattern hair loss by checking and correcting B12, folate, and thyroid levels, and considering an androgen profile if there are signs of excess androgen.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Crash dieting can cause temporary hair loss due to not getting enough energy for hair growth.

Female pattern hair loss in women can be due to hormones or aging.